{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:53:39Z","timestamp":1781495619240,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260358"],"award-info":[{"award-number":["82260358"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171906"],"award-info":[{"award-number":["82171906"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11517-026-03586-0","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:18:17Z","timestamp":1777681097000},"page":"2269-2285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interpretable survival benefit analytics framework for optimizing cancer treatment decision-making"],"prefix":"10.1007","volume":"64","author":[{"given":"Shuchao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-7875","authenticated-orcid":false,"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"1","key":"3586_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2441511","volume":"26","author":"Q Wang","year":"2025","unstructured":"Wang Q, Jin S, Wang Z, Ju Y, Wang K (2025) Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis. Cancer Biol Ther 26(1):2441511. https:\/\/doi.org\/10.1080\/15384047.2024.2441511","journal-title":"Cancer Biol Ther"},{"key":"3586_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110648","volume":"202","author":"C-N Wu","year":"2025","unstructured":"Wu C-N et al (2025) Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: a long-term, multicenter cohort study. Radiother Oncol 202:110648. https:\/\/doi.org\/10.1016\/j.radonc.2024.110648","journal-title":"Radiother Oncol"},{"issue":"1","key":"3586_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-025-00854-4","volume":"25","author":"QYH Ai","year":"2025","unstructured":"Ai QYH et al (2025) Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma. Cancer Imaging 25(1):32. https:\/\/doi.org\/10.1186\/s40644-025-00854-4","journal-title":"Cancer Imaging"},{"key":"3586_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106865","volume":"154","author":"W Xu","year":"2024","unstructured":"Xu W et al (2024) Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a network meta-analysis and cost-effectiveness analysis. Oral Oncol 154:106865. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106865","journal-title":"Oral Oncol"},{"key":"3586_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103522","volume":"70","author":"L Zhong","year":"2021","unstructured":"Zhong L et al (2021) A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: a multicentre study. EBioMedicine 70:103522. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103522","journal-title":"EBioMedicine"},{"key":"3586_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078276","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G (2024) Developing clinical prediction models: a step-by-step guide. BMJ. https:\/\/doi.org\/10.1136\/bmj-2023-078276","journal-title":"BMJ"},{"key":"3586_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1019638","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q et al (2022) Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma. Front Immunol 13:1019638. https:\/\/doi.org\/10.3389\/fimmu.2022.1019638","journal-title":"Front Immunol"},{"issue":"1","key":"3586_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07916-3","volume":"21","author":"D Zhou","year":"2021","unstructured":"Zhou D et al (2021) A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy. BMC Cancer 21(1):246. https:\/\/doi.org\/10.1186\/s12885-021-07916-3","journal-title":"BMC Cancer"},{"issue":"1","key":"3586_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"J Katzman","year":"2018","unstructured":"Katzman J, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y (2018) DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol 18(1):24. https:\/\/doi.org\/10.1186\/s12874-018-0482-1","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3586_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09217-9","volume":"22","author":"H Yu","year":"2022","unstructured":"Yu H, Huang T, Feng B, Lyu J (2022) Deep-learning model for predicting the survival of rectal adenocarcinoma patients based on a Surveillance, Epidemiology, and End Results analysis. BMC Cancer 22(1):210. https:\/\/doi.org\/10.1186\/s12885-022-09217-9","journal-title":"BMC Cancer"},{"issue":"11","key":"3586_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25881","volume":"3","author":"F Howard","year":"2020","unstructured":"Howard F, Kochanny S, Koshy M, Spiotto M, Pearson A (2020) Machine learning-guided adjuvant treatment of head and neck cancer. JAMA Netw Open 3(11):e2025881. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.25881","journal-title":"JAMA Netw Open"},{"key":"3586_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2023.1222612","volume":"6","author":"A Chaudhuri","year":"2023","unstructured":"Chaudhuri A et al (2023) Predictive digital twin for optimizing patient-specific radiotherapy regimens under uncertainty in high-grade gliomas. Front Artif Intell 6:1222612. https:\/\/doi.org\/10.3389\/frai.2023.1222612","journal-title":"Front Artif Intell"},{"issue":"10","key":"3586_CR13","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.mayocp.2021.02.032","volume":"96","author":"S Grundy","year":"2021","unstructured":"Grundy S et al (2021) High-intensity statins benefit high-risk patients: Why and how to do better. Mayo Clin Proc 96(10):2660\u20132670. https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.032","journal-title":"Mayo Clin Proc"},{"key":"3586_CR14","unstructured":"Rekkas A, Rijnbeek P, Kent D, Steyerberg E, van Klaveren D (2022) Individualized treatment effect was predicted best by modeling baseline risk in interaction with treatment assignment. Arxiv. https:\/\/doi.org\/arXiv:2205.01717"},{"key":"3586_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109943","volume":"189","author":"S Li","year":"2023","unstructured":"Li S et al (2023) A Rulefit-based prognostic analysis using structured MRI report to select potential beneficiaries from induction chemotherapy in advanced nasopharyngeal carcinoma: a dual-centre study. Radiother Oncol 189:109943. https:\/\/doi.org\/10.1016\/j.radonc.2023.109943","journal-title":"Radiother Oncol"},{"key":"3586_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103627","volume":"172","author":"E Tamburini","year":"2022","unstructured":"Tamburini E et al (2022) Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol 172:103627. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103627","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"3586_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45126-0","volume":"15","author":"H Liang","year":"2024","unstructured":"Liang H et al (2024) Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial. Nat Commun 15(1):1029. https:\/\/doi.org\/10.1038\/s41467-024-45126-0","journal-title":"Nat Commun"},{"issue":"8","key":"3586_CR18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i8.99036","volume":"31","author":"Z-Y Liang","year":"2025","unstructured":"Liang Z-Y et al (2025) Beyond the tumor region: peritumoral radiomics enhances prognostic accuracy in locally advanced rectal cancer. World J Gastroenterol 31(8):99036","journal-title":"World J Gastroenterol"},{"issue":"40","key":"3586_CR19","doi-asserted-by":"publisher","first-page":"66160","DOI":"10.18632\/oncotarget.10718","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X et al (2016) Adjuvant treatment may benefit patients with high-risk upper rectal cancer: a nomogram and recursive partitioning analysis of 547 patients. Oncotarget 7(40):66160","journal-title":"Oncotarget"},{"key":"3586_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101948","volume":"83","author":"G Bregni","year":"2020","unstructured":"Bregni G et al (2020) Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev 83:101948","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3586_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12634-7","volume":"24","author":"M Biniaz","year":"2024","unstructured":"Biniaz M, Moradi A, Basit MG, Pashaki A-A, Dehghan A, Mohammadian K (2024) Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach. BMC Cancer 24(1):863","journal-title":"BMC Cancer"},{"issue":"1","key":"3586_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99522-3","volume":"11","author":"L Meng","year":"2021","unstructured":"Meng L et al (2021) Development of a prediction model based on LASSO regression to evaluate the risk of non-sentinel lymph node metastasis in Chinese breast cancer patients with 1\u20132 positive sentinel lymph nodes. Sci Rep 11(1):19972. https:\/\/doi.org\/10.1038\/s41598-021-99522-3","journal-title":"Sci Rep"},{"issue":"6","key":"3586_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.27289","volume":"52","author":"B Yan","year":"2020","unstructured":"Yan B et al (2020) Preoperative assessment for high-risk endometrial cancer by developing anMRI- and clinical-based radiomics nomogram: a multicenter study. J Magn Reson Imaging 52(6):e27289. https:\/\/doi.org\/10.1002\/jmri.27289","journal-title":"J Magn Reson Imaging"},{"key":"3586_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1182\/hematology.2021000277","volume":"1","author":"A DeZern","year":"2021","unstructured":"DeZern A (2021) Lower risk but high risk. Hematology Am Soc Hematol Educ Program 1:428\u2013434. https:\/\/doi.org\/10.1182\/hematology.2021000277","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"3586_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112741","volume":"13","author":"P Msaouel","year":"2021","unstructured":"Msaouel P, Lee J, Thall PF (2021) Making patient-specific treatment decisions using prognostic variables and utilities of clinical outcomes. Cancers 13(11):2741","journal-title":"Cancers"},{"issue":"13","key":"3586_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.21037\/atm-22-33","volume":"10","author":"H Li","year":"2022","unstructured":"Li H et al (2022) Survival impact of additional induction chemotherapy in nasopharyngeal carcinoma with chronic hepatitis B infection: a retrospective, bi-center study. Ann Transl Med 10(13):731. https:\/\/doi.org\/10.21037\/atm-22-33","journal-title":"Ann Transl Med"},{"issue":"2","key":"3586_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.53832","volume":"6","author":"H Li","year":"2023","unstructured":"Li H et al (2023) Synergistic association of Hepatitis B surface antigen and plasma Epstein-Barr virus DNA load on distant metastasis in patients with nasopharyngeal carcinoma. JAMA Netw Open 6(2):e2253832. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.53832","journal-title":"JAMA Netw Open"},{"key":"3586_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110571","volume":"201","author":"Z Liang","year":"2024","unstructured":"Liang Z et al (2024) Guiding induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma with ternary classification of predicted individual treatment effect. Radiother Oncol 201:110571. https:\/\/doi.org\/10.1016\/j.radonc.2024.110571","journal-title":"Radiother Oncol"},{"issue":"10","key":"3586_CR29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jamia\/ocz036","volume":"26","author":"G Fang","year":"2019","unstructured":"Fang G, Annis IE, Elston-Lafata J, Cykert S (2019) Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort. J Am Med Inform Assoc 26(10):977\u2013988. https:\/\/doi.org\/10.1093\/jamia\/ocz036","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"3586_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4310\/23-SII781","volume":"17","author":"X Yan","year":"2024","unstructured":"Yan X, Xie J, Tu W, Jiang B, Kong L (2024) Scalable inference for individual treatment effect. Stat Interface 17(3):413\u2013423","journal-title":"Stat Interface"},{"key":"3586_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1034251","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J et al (2022) Machine learning models to predict in-hospital mortality in septic patients with diabetes. Front Endocrinol 13:1034251. https:\/\/doi.org\/10.3389\/fendo.2022.1034251","journal-title":"Front Endocrinol"},{"key":"3586_CR32","doi-asserted-by":"publisher","first-page":"98701","DOI":"10.1109\/ACCESS.2021.3093458","volume":"9","author":"D Liu","year":"2021","unstructured":"Liu D et al (2021) Time-to-event supervised genetic algorithm enables induction chemotherapy decision making for nasopharyngeal carcinoma. IEEE Access 9:98701\u201398711. https:\/\/doi.org\/10.1109\/ACCESS.2021.3093458","journal-title":"IEEE Access"},{"key":"#cr-split#-3586_CR33.1","unstructured":"Karmakar R (2022) Application of Genetic Algorithm"},{"key":"#cr-split#-3586_CR33.2","unstructured":"(GA) in Medical Science: A Review, in Second International Conference on Sustainable Technologies for Computational Intelligence: Proceedings of ICTSCI 2021, : Springer, pp. 83-94"},{"issue":"1","key":"3586_CR34","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.23.29984","volume":"222","author":"Y Zhu","year":"2024","unstructured":"Zhu Y et al (2024) Optimal size threshold for MRI- detected retropharyngeal lymph nodes to predict outcomes in nasopharyngeal carcinoma: a two- center study. AJR Am J Roentgenol 222(1):e2329984. https:\/\/doi.org\/10.2214\/AJR.23.29984","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"3586_CR35","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1007\/s00330-022-08785-5","volume":"32","author":"J Li","year":"2022","unstructured":"Li J et al (2022) Prognostic value of quantitative cervical nodal necrosis burden on MRI in nasopharyngeal carcinoma and its role as a stratification marker for induction chemotherapy. Eur Radiol 32(11):7710\u20137721. https:\/\/doi.org\/10.1007\/s00330-022-08785-5","journal-title":"Eur Radiol"},{"key":"3586_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08113-3","author":"W Huang","year":"2021","unstructured":"Huang W et al (2021) MRI of nasopharyngeal carcinoma: Parapharyngeal subspace involvement has prognostic value and influences T-staging in the IMRT era. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-021-08113-3","journal-title":"Eur Radiol"},{"key":"3586_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.radonc.2021.04.024","volume":"160","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) Extent of paranasal sinus involvement and its prognostic value in nasopharyngeal carcinoma: proposed modification in the current UICC\/AJCC staging system. Radiother Oncol 160:221\u2013227. https:\/\/doi.org\/10.1016\/j.radonc.2021.04.024","journal-title":"Radiother Oncol"},{"issue":"4","key":"3586_CR38","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.clnu.2020.10.019","volume":"40","author":"H Li","year":"2021","unstructured":"Li H et al (2021) Excessive vitamin B6 during treatment is related to poor prognosis of patients with nasopharyngeal carcinoma: a U-shaped distribution suggests low dose supplement. Clin Nutr 40(4):2293\u20132300. https:\/\/doi.org\/10.1016\/j.clnu.2020.10.019","journal-title":"Clin Nutr"},{"issue":"15","key":"3586_CR39","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad6118","volume":"69","author":"C Duan","year":"2024","unstructured":"Duan C et al (2024) GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer. Phys Med Biol 69(15):155018. https:\/\/doi.org\/10.1088\/1361-6560\/ad6118","journal-title":"Phys Med Biol"},{"key":"3586_CR40","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.2147\/JIR.S366922","volume":"15","author":"C Luo","year":"2022","unstructured":"Luo C et al (2022) RuleFit-based nomogram using inflammatory indicators for predicting survival in nasopharyngeal carcinoma, a bi-center study. J Inflamm Res 15:4803\u20134815. https:\/\/doi.org\/10.2147\/JIR.S366922","journal-title":"J Inflamm Res"},{"key":"3586_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.895014","volume":"12","author":"B Yang","year":"2022","unstructured":"Yang B et al (2022) Development and validation of a DeepSurv nomogram to predict survival outcomes and guide personalized adjuvant chemotherapy in non-small cell lung cancer. Front Oncol 12:895014. https:\/\/doi.org\/10.3389\/fonc.2022.895014","journal-title":"Front Oncol"},{"key":"3586_CR42","doi-asserted-by":"publisher","DOI":"10.1177\/2040622321992624","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Yang H, Moi S, Chuang L, Yang C (2021) Identification of mortality-risk-related missense variant for renal clear cell carcinoma using deep learning. Ther Adv Chronic Dis 12:2040622321992624. https:\/\/doi.org\/10.1177\/2040622321992624","journal-title":"Ther Adv Chronic Dis"},{"issue":"10","key":"3586_CR43","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1073\/pnas.1804597116","volume":"116","author":"SR K\u00fcnzel","year":"2019","unstructured":"K\u00fcnzel SR, Sekhon JS, Bickel PJ, Yu B (2019) Metalearners for estimating heterogeneous treatment effects using machine learning. Proc Natl Acad Sci U S A 116(10):4156\u20134165","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"523","key":"3586_CR44","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/01621459.2017.1319839","volume":"113","author":"S Wager","year":"2018","unstructured":"Wager S, Athey S (2018) Estimation and inference of heterogeneous treatment effects using random forests. J Am Stat Assoc 113(523):1228\u20131242","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"3586_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0296951","volume":"19","author":"L Chen","year":"2024","unstructured":"Chen L, Yi G (2024) AteMeVs: an R package for the estimation of the average treatment effect with measurement error and variable selection for confounders. PLoS One 19(9):e0296951. https:\/\/doi.org\/10.1371\/journal.pone.0296951","journal-title":"PLoS One"}],"container-title":["Medical & Biological Engineering & Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-026-03586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11517-026-03586-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-026-03586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:16:42Z","timestamp":1781493402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11517-026-03586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3586"],"URL":"https:\/\/doi.org\/10.1007\/s11517-026-03586-0","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"value":"0140-0118","type":"print"},{"value":"1741-0444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have influenced the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}